Autoimmune pancreatitis – diagnostic consensus – editorial

Česká verzia

Authors: Antonín Vavrečka
Authors place of work: Klinika gastroenterológie LF SZU a UN Bratislava, Slovenská republika, prednosta doc. MUDr. Marián Bátovský, CSc., mim. prof.
Published in the journal: Vnitř Lék 2015; 61(2): 93-94
Category: Editorial

Zdroje

1. Dítě P, Trna J, Novotný I et al. Chronic pancreatitis in 2011. Vnitř Lék 2011; 57(11): 891–896.

2. Dítě P, Nechutová H, Uvirová M et al. Autoimmune pancreatitis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Rep 2014; 158(1): 17–22.

3. Rasch S, Phillip V, Weirich G et al. Auitoimmune pancreatitis – treatment and pitfalls in diagnostics. Internist (Berl) 2014; 55(10): 1231–1241.

4. Song TJ, Kim MH, Kim MJ et al. Clinical validation of the international consensus diagnostic criteria and algorithms for autoimmune pancreatitis: combined IAP and KPBA meeting 2013 report. Pancreatology 2014; 14(4): 233–237.

5. Okazaki K, Yanagawa M, Mitsuyama T et al. Recent Advances in the Concept and Pathogenesis of IgG4-Related Disease in the Hepato-Bilio-Pancreatic System. Gut Liver 2014; 8(5): 462–470.

6. Kamisawa T, Ryu JK, Kim MH et al. Recent Advances in the Diagnosis and Management of Autoimmune Pancreatitis. Gut Liver 2013; 7(4): 394–413.

7. Hart PA, Topazian MD, Witzig TE et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2012; 62(11): 1607–1615.

8. Iwashita T, Yasuda I, Doi S et al. Use of samples from endoscopic ultrasound-guided 19-gauge fine-nedle aspiration in diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol 2012; 10(3): 316–322.

9. Moon SH, Kim MH, Park DH et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study.Gut 2008; 57(12): 1704–1712.